GRI Bio Management
Management criteria checks 1/4
GRI Bio's CEO is W. Hertz, appointed in Jan 2009, has a tenure of 16.08 years. total yearly compensation is $842.01K, comprised of 48% salary and 52% bonuses, including company stock and options. directly owns 0.047% of the company’s shares, worth $2.04K. The average tenure of the management team and the board of directors is 9 years and 1.8 years respectively.
Key information
W. Hertz
Chief executive officer
US$842.0k
Total compensation
| CEO salary percentage | 48.0% |
| CEO tenure | 16.1yrs |
| CEO ownership | 0.05% |
| Management average tenure | 9yrs |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$8m |
| Jun 30 2024 | n/a | n/a | -US$8m |
| Mar 31 2024 | n/a | n/a | -US$13m |
| Dec 31 2023 | US$842k | US$404k | -US$13m |
Compensation vs Market: W.'s total compensation ($USD842.01K) is above average for companies of similar size in the US market ($USD638.32K).
Compensation vs Earnings: Insufficient data to compare W.'s compensation with company performance.
CEO
W. Hertz (53 yo)
16.1yrs
Tenure
US$842,014
Compensation
Dr. W. Marc Hertz, Ph.D. co-founded Multimeric Biotherapeutics, Inc. in 2008 and also served as its Chief Executive Officer. He is Co-Founder and President of GRI Bio, Inc. since April 20, 2023 and served...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 16.1yrs | US$842.01k | 0.047% $ 2.0k | |
| Co-Founder & Chief Medical Officer | no data | US$461.10k | 0.021% $ 909.7 | |
| CFO & Corporate Secretary | 1.8yrs | US$665.28k | 0.000020% $ 0.9 | |
| Co-Founder & Chief Scientific Officer | 16.1yrs | no data | 0.021% $ 909.7 | |
| Interim Chief Executive Officer of Global Reporting Initiative | less than a year | no data | no data |
9.0yrs
Average Tenure
56yo
Average Age
Experienced Management: GRI's management team is seasoned and experienced (9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 1.8yrs | US$842.01k | 0.047% $ 2.0k | |
| Independent Director | 1.8yrs | US$129.44k | 0% $ 0 | |
| Director | 4yrs | US$1.30m | 0.000030% $ 1.3 | |
| Independent Chairman of the Board | 1.8yrs | US$152.84k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$134.33k | 0% $ 0 |
1.8yrs
Average Tenure
53yo
Average Age
Experienced Board: GRI's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/11 17:26 |
| End of Day Share Price | 2025/02/11 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
GRI Bio, Inc. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Edward Woo | Ascendiant Capital Markets LLC |
| Matthew Keller | H.C. Wainwright & Co. |